BVN Ablation: OptaBlate and Intracept Options
- Posted on: May 26 2025
BVN ablation (basivertebral nerve ablation) uses radiofrequency energy on a nerve inside the vertebral bone. It is considered for selected vertebrogenic low back pain—pain linked to vertebral endplate inflammation and matching Modic type 1 or 2 changes—not for every cause of back pain. This page explains what the procedure is, how OptaBlate and Intracept fit, and why conservative care still comes first. Related reading: vertebral body pain.
Quick Answer: BVN Ablation
- Targets the basivertebral nerve inside the vertebral body for selected vertebrogenic pain.
- FDA-cleared options discussed here include OptaBlate (first) and Intracept.
- Labeling describes chronic low back pain for 6+ months after conservative care, with Modic type 1 or 2 changes at L3–S1 on MRI.
- It does not treat infection, tumor, acute fracture, or a compressive disc herniation in the canal.
- Fever, new weakness, bladder or bowel changes, or severe pain after trauma need emergency care.
What BVN Ablation Treats
The basivertebral nerve runs inside the vertebral body and can carry pain signals from inflamed endplates. When MRI shows Modic type 1 or 2 changes that match the exam, and pain has lasted despite conservative care, basivertebral nerve ablation may be discussed.
Care usually starts with activity changes, physical therapy as a partner, and medicines when appropriate. Imaging and exam must fit before a procedure is discussed. BVN ablation does not treat infection, tumor, acute fracture, or radiculopathy from a compressive disc herniation. For disc patterns, see the herniated disc resource. Broader back-pain context: low back pain.
Who May Be a Candidate
FDA labeling for both OptaBlate and Intracept describes a similar selected group: adults with chronic low back pain of at least six months that has not responded to at least six months of conservative care, with features consistent with Type 1 or Type 2 Modic changes at L3 through S1 on MRI [Source][Source]. Modic changes are marrow patterns first described on MRI [Source].
Your clinician still matches symptoms, exam, and full imaging—not an MRI report alone. Instability, active infection, tumor, and other red-flag diagnoses change the plan.
Conservative Care Comes First
Most people with low back pain start with paced activity, physical therapy, and short courses of medicines when safe. Chiropractors and therapists can be partners for mobility when appropriate and safe for the diagnosis. A procedure is not the first step for every Modic finding on MRI.
If pain continues after a meaningful trial of conservative care and the imaging pattern fits vertebrogenic pain, BVN ablation may enter the discussion. Expectations should be individualized—this page does not quote outcome percentages or promise a cure.
OptaBlate and Intracept Options
At SpinePain Solutions, basivertebral nerve ablation may be done with OptaBlate or Intracept. The OptaBlate BVN Intraosseous Nerve Ablation System (Stryker) is FDA-cleared under 510(k) K250213 (decision May 15, 2025). Patients searching for Stryker basivertebral nerve ablation are often looking for this platform. Service details: OptaBlate.
Intracept is a related FDA-cleared basivertebral nerve ablation platform. Original clearance for the Intracept Intraosseous Nerve Ablation System was 510(k) K153272 (July 9, 2016), with later clearances such as K222281 (October 26, 2022). Both are FDA-cleared devices (510(k)), not drug approvals.
Both systems place a probe inside the vertebral body under imaging guidance and deliver radiofrequency energy to the basivertebral nerve. Clearance is not a promise of outcome. Compare devices on the OptaBlate vs Intracept page. Service overview: basivertebral nerve ablation.
What the Evidence Means in Plain Language
Randomized trials and later follow-up studies have evaluated intraosseous basivertebral nerve ablation for selected chronic low back pain with Modic changes, including the SMART and INTRACEPT trials and related long-term reports on the Intracept platform [Source][Source][Source]. OptaBlate is a later FDA-cleared system with similar labeled indications; it was not the device used in those trials. Systematic reviews summarize the published evidence base [Source]. Results are used to counsel selected patients; they do not guarantee the same result for every person.
What Happens During the Procedure
Under sedation and local anesthesia, imaging guidance is used to advance an access tool through the pedicle into the vertebral body. A radiofrequency probe is positioned near the basivertebral nerve, and controlled heat is applied to ablate the nerve. People usually go home the same day when medically appropriate. There is no implant left behind.
Aftercare typically includes activity pacing for a short period and a follow-up visit. Temporary increase in axial pain can occur as treated bone settles. Call sooner for fever, progressive weakness, or new bowel or bladder changes.
How BVN Ablation Differs From Other Ablation
Traditional lumbar radiofrequency ablation often targets nerves that supply facet joints or the sacroiliac joint. Those procedures treat joint-driven pain patterns. BVN ablation targets a nerve inside the vertebral bone for selected endplate-driven (vertebrogenic) pain. They are different tools for different diagnoses. Overview: radiofrequency ablation.
Risks to Understand
Risks include temporary pain flare, bleeding, infection, nerve or spinal cord injury, fracture around the access path, and incomplete or temporary relief. Rare but serious events are why candidacy, imaging review, and informed consent matter. Your clinician should review personal risks before you agree.
BVN Ablation on Long Island
SpinePain Solutions evaluates vertebrogenic pain and BVN ablation options at Bay Shore, Commack, and Farmingdale (office locations; Commack). The procedure itself is done at a hospital or surgery center, not in the office. Dr. Amit Sharma, Chief, Division of Pain Medicine at Good Samaritan University Hospital. Call or text 631-310-0000.
Plans start with the safest step that fits your imaging and exam. You leave knowing what to watch for and when to escalate care.
Emergency Warning Signs
Call 911 for fever with spine pain, new weakness or numbness, bladder or bowel changes, saddle numbness, severe pain after trauma, or concerning new neurologic symptoms with a history of cancer.
Dr. Amit Sharma & our minimally invasive pain & spine team.
Frequently Asked Questions
What is BVN ablation?
BVN ablation (basivertebral nerve ablation) uses radiofrequency energy on a nerve inside the vertebral bone. It is aimed at selected vertebrogenic low back pain linked to endplate inflammation and matching Modic type 1 or 2 changes—not at every cause of back pain.
When is low back pain an emergency instead of BVN ablation planning?
Call 911 or go to the nearest emergency room for fever with spine pain, new weakness or numbness, bladder or bowel changes, saddle numbness, severe pain after trauma, or concerning symptoms with a history of cancer. Elective BVN ablation visits are not for those emergencies. Call SpinePain Solutions at 631-310-0000 for non-emergency questions.
Who may be a candidate for basivertebral nerve ablation?
FDA labeling for OptaBlate and Intracept describes adults with chronic low back pain for at least six months that has not responded to at least six months of conservative care, with Type 1 or Type 2 Modic changes at L3 through S1 on MRI. Your exam and full imaging review still decide whether a procedure fits.
What is the difference between OptaBlate and Intracept?
Both are FDA-cleared systems that ablate the basivertebral nerve inside the vertebral body for selected vertebrogenic pain. OptaBlate is a Stryker system (510(k) K250213). Intracept is a Relievant/Boston Scientific platform with original clearance K153272 and later clearances such as K222281. Clearance is not a promise of outcome. Device choice depends on clinical judgment and availability.
How is BVN ablation different from facet or sacroiliac radiofrequency ablation?
Facet and sacroiliac radiofrequency ablation target nerves outside the vertebral body that supply joints. BVN ablation targets a nerve inside the bone for selected endplate-driven (vertebrogenic) pain. They treat different pain sources and are not interchangeable.
Does BVN ablation treat a herniated disc?
No. Basivertebral nerve ablation is not a treatment for a compressive disc herniation in the spinal canal. Disc-related leg pain follows a different evaluation path. See our herniated disc resource for that pattern.
What are the main risks?
Risks include temporary increase in pain, bleeding, infection, nerve or spinal cord injury, fracture around the access path, and incomplete or temporary relief. Your clinician should review personal risks before you agree.
Where can I get evaluated on Long Island?
SpinePain Solutions evaluates vertebrogenic pain and BVN ablation options at Bay Shore, Commack, and Farmingdale. The procedure itself is done at a hospital or surgery center, not in the office. Call or text 631-310-0000.
Dr. Amit Sharma & our minimally invasive pain & spine team.
Medical References
- Modic MT, et al. Degenerative disk disease: assessment of changes in vertebral body marrow with MR imaging. Radiology. 1988. PMID 3336678.
- Fischgrund JS, et al. Intraosseous basivertebral nerve ablation for the treatment of chronic low back pain: a prospective randomized double-blind sham-controlled multi-center study (SMART). Eur Spine J. 2018. PMID 29423885.
- Khalil JG, et al. A prospective, randomized, multicenter study of intraosseous basivertebral nerve ablation for the treatment of chronic low back pain (INTRACEPT). Spine J. 2019. PMID 31229663.
- Fischgrund JS, et al. Long-term outcomes following intraosseous basivertebral nerve ablation: 5-year treatment arm results. Eur Spine J. 2020. PMID 32451777.
- Conger A, et al. The effectiveness of intraosseous basivertebral nerve radiofrequency ablation for vertebrogenic low back pain: an updated systematic review with single-arm meta-analysis. Pain Med. 2022. PMID 35856331.
- US Food and Drug Administration. 510(k) K250213, OptaBlate BVN Intraosseous Nerve Ablation System. Decision May 15, 2025. accessdata.fda.gov.
- US Food and Drug Administration. 510(k) K153272, Intracept Intraosseous Nerve Ablation System. Decision July 9, 2016. accessdata.fda.gov.
- US Food and Drug Administration. 510(k) K222281, Intracept Intraosseous Nerve Ablation System. Decision October 26, 2022. accessdata.fda.gov.
Posted in: News, Special Report
